FOR INVESTORS

Disease outmatched by the science of degradation

FOR INVESTORS

FOR INVESTORS

Nurix is a clinical-stage biopharmaceutical company advancing targeted protein degradation as the next frontier in drug development.

Minimum 15 minutes delayed. Source: LSEG

SEC Filings

October 13, 2026

Report of unscheduled material events or corporate event

October 13, 2026

Quarterly report which provides a continuing view of a company's financial position

October 02, 2026

Filed by "insiders" prior intended sale of restricted stock.